ArticleNPJ precision oncology2026

Distinct immune microenvironment in HER2-low triple-negative breast cancer underlies inferior response to immunotherapy.

Hewei Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.